Handelsavisen
prelaunch
Companies Health Care BNBX
BN
BNBX Nasdaq Life Sciences Tools & Services

Bnb Plus Corp.

$0,37
Open in Charts → Attach watcher ⌖
USD
Set alert
LatestBNB Plus Corp. files critical 8-K, Handelsavisen revises thesis
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
3,3M USD
P/E
EV / Rev
Div yield
Op margin
ROE
-202,0 %
Net margin
Debt / equity
Beta
52w range
Volume
51,3k
Day range
$0,15–$0,19
Prev close
$0,38
Open
$0,16
Next earnings
2026-07-28
Ex-dividend
TR 1Y
About

BNB Plus Corp. operates as a biotechnology and digital asset company, generating revenue through therapeutic DNA production, DNA tagging and security products, and a digital asset treasury strategy involving BNB tokens and stablecoins.

Business. BNB PLUS CORP. (BNBX) is an investment management and fund operator that provides asset management and custody services. The company operates within the Financials sector, specifically under the Banking & Investment Services business sector. BNB PLUS CORP. is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding operating segments and geographic revenue mix are not available.

Classification85 %
SectorHealth Care
Industry groupLife Sciences Tools & Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-07-28 · estimated
See all catalysts →

At a glance

Score
26
composite score
Valuation
valuation pending
Analysts
not yet wired
Ownership
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability
-202,0 %
return on equity
Quality
61
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • MARKETSBNB Plus Corp. files critical 8-K, Handelsavisen revises thesis2026-07-13
  • Sector rotation

    Sector1D1Mvs mkt
    Communication Services+2,2 %−5,5 %+1,3 %
    Materials+2,2 %+2,9 %+1,3 %
    Energy+0,8 %+5,9 %−0,1 %
    Health Care · THIS SECTOR+0,7 %−1,3 %−0,2 %
    Real Estate+0,5 %+5,3 %−0,5 %
    Consumer Discretionary+0,3 %+9,4 %−0,6 %
    Information Technology+0,1 %+8,1 %−0,8 %
    Financials−0,5 %−2,7 %−1,4 %
    Consumer Staples−0,5 %+3,2 %−1,5 %
    Industrials−1,0 %−0,3 %−2,0 %
    Utilities−1,9 %+28,2 %−2,8 %

    Developing storylines

    No tracked sagas currently linked to BNBX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-15 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-07-28 · estimated
    • Macro
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · 2026-07-13

    Composite-score breakdown

    Score breakdown26
    Valuation+12
    Sentiment+30
    Risk penalty−16
    Missing signals−3

    Synthesis

    Business

    BNB PLUS CORP. (BNBX) is an investment management and fund operator that provides asset management and custody services. The company operates within the Financials sector, specifically under the Banking & Investment Services business sector. BNB PLUS CORP. is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification85 %
    SectorHealth Care
    Industry groupLife Sciences Tools & Services
    AI synthesis
    GENERATED

    BNB Plus Corp. maintains a debt-free capital structure with a debt-to-equity ratio of 0.0 and a current ratio of 1.82, indicating adequate short-term liquidity coverage despite a net loss of $25.26 million in Q2 2026. The company holds $949,091 in cash and equivalents, supplemented by significant digital asset holdings including $1.34 million in digital assets, $3.71 million in digital asset receivables, and $5.40 million in digital asset trust investments. The market capitalization stands at $3.25 million, trading at a price-to-book ratio of 0.34, reflecting a deep discount to tangible book value of $12.51 million.

    Profitability metrics are severely negative, with a return on equity of -2.02 and return on assets of -1.85, driven by operating losses of $25.46 million against gross profit of $1.14 million. The company reports substantial non-cash expenses, including $8.83 million in warrants issued to consultants and $968,064 in stock-based compensation, alongside unrealized losses on digital assets. These losses have accumulated to a deficit of $404.45 million in retained earnings, eroding shareholder equity despite recent capital raises.

    Key takeaways
    • Debt-free balance sheet with $12.51 million in equity, but eroded by $404.45 million in accumulated deficit.
    • High dilution risk with diluted shares (8.87M) nearly double the basic share count (4.77M) due to warrants and options.
    • Strategic pivot to digital asset treasury, holding $10.45 million in digital assets and trust investments.
    • Operating losses of $25.46 million in Q2 2026, driven by non-cash expenses and unrealized digital asset losses.
    • Recent capital raises of $24.90 million via PIPE and ATM offerings to fund operations and digital asset purchases.
    • Going-concern doubts flagged in filings, highlighting dependency on future capital or revenue growth.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    The company trades at a 0.34 price-to-book ratio, suggesting significant undervaluation relative to its tangible book value of $9.4 million.

    Net income improved by 53.9% year-over-year in FY2025, indicating a meaningful reduction in losses compared to the prior period.

    Total assets surged 188.2% year-over-year to $12.8 million in FY2025, reflecting substantial balance sheet expansion and growth potential.

    Equity grew 296.7% year-over-year to $9.1 million in FY2025, demonstrating strong capital accumulation despite ongoing operational losses.

    The debt-to-equity ratio of 0.0 ranks above the cohort median, indicating a conservative capital structure with minimal leverage risk.

    BEAR CASE · 5

    The company faces high dilution risk, which threatens existing shareholder value and could significantly reduce earnings per share over time.

    High liquidity risk flags suggest potential difficulties in meeting short-term obligations, raising concerns about financial stability and operational continuity.

    Return on equity stands at -2.02%, placing the company in the bottom quartile of its investment management cohort peers.

    Operating income deteriorated to -$16.0 million in FY2025, highlighting persistent inability to generate core operational profitability from business activities.

    Free cash flow was negative $14.1 million in FY2024, indicating severe cash burn and reliance on external financing for operations.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Operating income -$25.5M.

    Revenue
    Operating income-$25.5M
    Net income-$25.3M
    Free cash flow
    EPS
    Operating cash flow
    Financials
    Income statement
    Revenue
    Gross profit$1.1M
    Operating income-$25.5M
    Net income-$25.3M
    Balance sheet
    Total assets$13.6M
    Total liabilities$1.5M
    Total equity$12.5M
    Cash & equivalents$949.1k
    Long-term debt
    Cash flow
    Operating cash flow
    CapEx
    Free cash flow
    SBC$968.1k
    Highlights
    • Operating income -$25.5M

    Valuation FY

    Market price
    $0,37
    Market cap
    $3.3M
    Enterprise value
    $2.3M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    0.3x
    P / Tangible book
    0.3x
    Tangible book
    $9.4M
    Net cash
    $949.1k
    Current ratio
    1.8
    Debt / equity
    ROA
    -1.9%
    ROE
    -2.0%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    85.9%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Customers1
    ANON:CUST:BNBX.O:P29ANON:CUST:BNBX.O:P29Customer88%

    Supply chain

    Vendors → BNBX ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSBNBXBNBXBnb Plus Corp.1 entityANON:CUST:BNBX.O:P29
    0 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-07-13

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskHigh
    Liquidity riskHigh
    Filing-based flags
    • Diluted share count is materially above the basic share count.
    • Filings reference going-concern or substantial-doubt language.
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    ROE-202,0 %Bottom quartile
    D/E0,00Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 724 004 sh12 grants8 insiders
    • Haft JamesDirector · Non-Qualified Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
    • Kruger JoshuaDirector, Chairman of the Board · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
    • Ceccoli Joseph D.Director · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
    • Murrah JudithDirector · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
    • CATELL ROBERT BDirector · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
    • SHAMASH YACOV ADirector · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
    • Haft JamesDirector · Non-Qualified Stock Option (right to buy) → Common StockAcquired 12 270 @ $1,31grant · 2026-02-02
    • Haft JamesDirector · Incentive Stock Option (right to buy) → Common StockAcquired 80 730 @ $1,31grant · 2026-02-02
    • Shorrock ClayChief Executive Officer · Incentive Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
    • Jantzen BethChief Financial Officer · Non-Qualified Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
    • Jantzen BethChief Financial Officer · Incentive Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
    • Shorrock ClayChief Executive Officer · Non-Qualified Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Enterprise Value
      market_cap - net_cash
    • Return On Equity
      net_income / total_equity
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    Source documents
    • BNB PLUS CORP. company facts · 2026-07-13
    • BNB PLUS CORP. 10-Q 2026-05-15 · 2026-07-13
    • BNB PLUS CORP. 10-Q 2026-02-12 · 2026-07-13
    • BNB PLUS CORP. 10-K 2025-12-22 · 2026-07-13
    • BNB PLUS CORP. 10-Q 2025-08-14 · 2026-07-13
    • 8-K (sec_8k_material) on BNBX · 2026-07-13
    • BNB Plus Corp Market data — analyst estimates · 2026-07-13
    • BNB PLUS CORP. HA canonical relationships · 2026-07-13

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $07 insiders · last 365d
    • Jantzen BethChief Financial Officer · Common StockOther 18 691 · 2025-10-17
    • Ceccoli Joseph D.Director · Common StockOther 22 511 · 2025-10-17
    • CATELL ROBERT BDirector · Common StockOther 22 511 · 2025-10-17
    • Schmalz Elizabeth MDirector · Common StockOther 22 511 · 2025-10-17
    • SHAMASH YACOV ADirector · Common StockOther 22 511 · 2025-10-17
    • Murrah JudithDirector · Common StockOther 18 691 · 2025-10-17
    • Shorrock ClayChief Executive Officer · Common StockOther 18 691 · 2025-10-17

    Short positioning

    173.3Kshares short+213.0% vs prior
    1days to cover
    33.7%short of daily vol
    399fails-to-deliver
    as of 2026-06-30 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BNBXCanonical
    Nasdaq · USD

    Intel & risk

    What changed

    no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

    • Narrative— → —medium
    • Conclusion— → —medium
    vs prior analysis 10 days ago
    peak dispatch · 2026-07-13
    OSINT findings
    Dilution riskHigh
    Liquidity riskHigh
    Diluted share count is materially above the basic share count.
    Filings reference going-concern or substantial-doubt language.
    Source documents mention dilution or offering risk.
    Relationship graph
    BNBXANON:CUSLife Sciences
    This companySectorCustomers

    Evidence & claims

    From filings & derived data
    • Total assets (annual): USD 20.7MUnknown
    • Shares outstanding (annual): 4.77MUnknown
    • Cash & equivalents (annual): USD 2.45MUnknown
    • Shareholders' equity (annual): USD 18.84MUnknown
    • Current assets (annual): USD 5.11MUnknown
    • Total liabilities (annual): USD 2.24MUnknown
    • Current liabilities (annual): USD 2.21MUnknown
    • Gross profit (annual): USD 838.91KUnknown
    • EPS (basic) (annual): USD-PER-SHARES -134Unknown
    • Total operating expenses (annual): USD 16.89MUnknown
    • Cost of revenue (annual): USD 1.3MUnknown
    • Pre-tax income (annual): USD -15.64MUnknown
    • Capex (annual): USD 313.12KUnknown
    • R&D expense (annual): USD 6.02MUnknown
    • Operating income (annual): USD -16.05MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES -134Unknown
    • Net income (annual): USD -15.16MUnknown
    • Shares outstanding (annual): 54.11MUnknown
    • Total liabilities (annual): USD 3.42MUnknown
    • Current liabilities (annual): USD 2.39MUnknown
    • Current assets (annual): USD 11.28MUnknown
    • Cash & equivalents (annual): USD 9.29MUnknown
    • Shareholders' equity (annual): USD 12.75MUnknown
    • Total assets (annual): USD 15.97MUnknown
    Showing 24 of 35 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-13 22:24 UTCFILINGMaterial 8-K
    2026-07-13 21:59 UTCEVENTHa Price Move BNBX extraordinary down move (-49.682% 1d, 4.07x sigma) on x3.759 volume
    2026-07-03 04:32 UTCFILINGMaterial 8-K
    2026-05-27FILINGFORM 8-K →
    2026-05-15FILING10-Q filing →
    2026-04-29FILINGFORM 8-K →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Net USD -25.3M
    2026-03-27 00:00 UTCINSIDER6 insider transactions — 2026-03 6 derivative
    2026-03-27INSIDERHaft James acquired 77.0k sh Non-Qualified Stock Option (right to buy) — Director
    2026-03-27INSIDERKruger Joshua acquired 77.0k sh Incentive Stock Option (right to buy) — Director, Chairman of the Board
    2026-03-27INSIDERCeccoli Joseph D. acquired 77.0k sh Incentive Stock Option (right to buy) — Director
    2026-03-27INSIDERMurrah Judith acquired 77.0k sh Incentive Stock Option (right to buy) — Director
    2026-03-27INSIDERCATELL ROBERT B acquired 77.0k sh Incentive Stock Option (right to buy) — Director
    2026-03-27INSIDERSHAMASH YACOV A acquired 77.0k sh Incentive Stock Option (right to buy) — Director
    2026-03-24FILINGDEF 14A filing →
    2026-03-24FILINGFORM 8-K →
    2026-02-12FILING10-Q filing →
    2026-02-05FILINGFORM 8-K →
    2026-02-02 00:00 UTCINSIDER2 insider transactions — 2026-02 2 derivative
    2026-02-02INSIDERHaft James acquired 12.3k sh Non-Qualified Stock Option (right to buy) — Director
    2026-02-02INSIDERHaft James acquired 80.7k sh Incentive Stock Option (right to buy) — Director
    2026-01-22FILINGFORM 8-K →
    2025-12-31EARNINGSQuarterly results — Q3 2025 Net USD -18.6M
    2025-12-31EARNINGSQuarterly results — Q3 2025
    2025-12-30FILING424B3 filing →
    2025-12-22FILING10-K filing →
    2025-12-15 00:00 UTCINSIDER4 insider transactions — 2025-12 4 derivative
    2025-12-15FILINGFORM 8-K →
    2025-12-15INSIDERShorrock Clay acquired 42.2k sh Incentive Stock Option (right to buy) — Chief Executive Officer
    2025-12-15INSIDERJantzen Beth acquired 42.2k sh Non-Qualified Stock Option (right to buy) — Chief Financial Officer
    2025-11-17FILINGFORM 8-K →
    2025-10-17 00:00 UTCINSIDER7 insider transactions — 2025-10
    2025-10-17INSIDERSchmalz Elizabeth M transacted 22.5k sh — Director
    2025-10-17INSIDERCeccoli Joseph D. transacted 22.5k sh — Director
    2025-10-17INSIDERCATELL ROBERT B transacted 22.5k sh — Director
    2025-10-17INSIDERJantzen Beth transacted 18.7k sh — Chief Financial Officer
    2025-10-17INSIDERSHAMASH YACOV A transacted 22.5k sh — Director
    2025-10-17INSIDERMurrah Judith transacted 18.7k sh — Director
    Showing the 40 most recent of 47 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-15 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage